Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Alva AS; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Hansra D; Cancer Treatment Centers of America, Atlanta, GA., Calfa CJ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Khalil MF; Lehigh Valley Cancer Institute, Allentown, PA., Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA., Crilley P; Cancer Treatment Centers of America, Philadelphia, PA., Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC., Haslem DS; Intermountain Logan Cancer Clinic, Logan, UT., Shrestha S; Cancer Treatment Centers of America, Tulsa, OK., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Butler NL; American Society of Clinical Oncology, Alexandria, VA., Warren SL; American Society of Clinical Oncology, Alexandria, VA., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Ranasinghe S; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Aug 01; Vol. 39 (22), pp. 2443-2451. Date of Electronic Publication: 2021 Apr 12.

Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Autor: Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Dib EG; Michigan Cancer Research Consortium, Ypsilanti, MI., Haggstrom DE; Levine Cancer Institute, Charlotte, NC., Alguire KB; Cancer Research Consortium of West Michigan, Grand Rapids, MI., Calfa CJ; Sylvester Comprehensive Cancer Center, Plantation, FL., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA., Crilley PA; Cancer Treatment Centers of America, Philadelphia, PA., Gaba AG; Sanford Health, Sioux Falls, SD., Marr AS; University of Nebraska Medical Center, Omaha, NE., Sangal A; Cancer Treatment Centers of America, Phoenix, AZ., Thota R; Intermountain Healthcare, Salt Lake City, UT., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Islam S; American Society of Clinical Oncology, Alexandria, VA., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 757-766.

Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.

Autor: Mackay CB; Department of Health Policy and Management, University of Kansas Medical Center, Fairway, Kansas.; University of Kansas Cancer Center, Fairway, Kansas., Antonelli KR; American Society of Clinical Oncology, Alexandria, Virginia., Bruinooge SS; American Society of Clinical Oncology, Alexandria, Virginia., Saint Onge JM; Department of Health Policy and Management, University of Kansas Medical Center, Fairway, Kansas., Ellis SD; Department of Health Policy and Management, University of Kansas Medical Center, Fairway, Kansas.; University of Kansas Cancer Center, Fairway, Kansas.

Publikováno v: Cancer [Cancer] 2017 Aug 01; Vol. 123 (15), pp. 2893-2900. Date of Electronic Publication: 2017 Mar 23.